By activating both receptors, tirzepatide may provide a more robust signal to the brain regarding satiety and may have different effects on how the body breaks down fat and stores energy
Katie, I want you to know I am sorry. She also added, Part of that is acknowledging the past where we played any part in the shame that people carry with them, and, so, Katie, thank you for engaging in this discussion so productively. She also acknowledged every Katie whose out there who hasnt heard this message it is important for me that you hear it because we can only start to hope for advocacy and health equity when we address our internalized bias. For a long time, the messaging was, get some willpower, go to the gym, eat less, why cant you lose weight? Its not about a lack of strength, these medications are helping people with chronic disease like obesity to live a better life
Understanding the risks is vital for those considering GLP-1 medications
That is already how Medicare handles the injectable PCSK9 drugs
Dubrow recommends tirzepatide as the best GLP-1 available